Revance Therapeutics News, Revance Therapeutics Quote, RVNC Quote

Revance Therapeutics (NQ:RVNC) Delayed: 3.77 +0.13 (3.57%)

Prev. Close

$3.64

Open

$3.64

52 Wk High

$41.12

52 Wk Low

$12.35

Day High

$3.81

Day Low

$3.62

P/E

N/A

EPS

$-27.14

Volume

874,264

Friends, Peers and Foes (?): C2HN34 (more...)

Apr 17, 2024 04:35 PM Form 4 Revance Therapeutics, For: Apr 16 Filed by: Jordan Erica
Apr 12, 2024 08:00 AM Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Apr 9, 2024 01:18 PM Form SC 13G/A Revance Therapeutics, Filed by: JPMORGAN CHASE & CO
Mar 27, 2024 04:05 PM Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 21, 2024 04:10 PM Form DEFA14A Revance Therapeutics,
Mar 21, 2024 04:08 PM Form DEF 14A Revance Therapeutics, For: May 01
Mar 19, 2024 06:46 PM Form 4 Revance Therapeutics, For: Mar 15 Filed by: Sjuts Dustin S
Mar 19, 2024 06:45 PM Form 4 Revance Therapeutics, For: Mar 15 Filed by: Moxie Dwight
Mar 19, 2024 06:44 PM Form 4 Revance Therapeutics, For: Mar 15 Filed by: Schilke Tobin
Mar 19, 2024 06:43 PM Form 4 Revance Therapeutics, For: Mar 15 Filed by: Foley Mark J

Entities mentioned with RVNC